Sonoma Pharmaceuticals
SNOA
#10772
Rank
S$7.79 M
Marketcap
S$1.63
Share price
0.00%
Change (1 day)
-65.48%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2025 (TTM): -S$4.11 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are S$16.93 Million. In 2024 the company made an earning of -S$5.78 Million a decrease over its 2023 earnings that were of -S$5.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$4.11 Million-28.8%
2024 -S$5.78 Million0.54%
2023 -S$5.74 Million-31.5%
2022 -S$8.38 Million16.86%
2021 -S$7.17 Million194.32%
2020 -S$2.44 Million-58.76%
2019 -S$5.91 Million-65.66%
2018 -S$17.21 Million4.84%
2017 -S$16.41 Million-2.17%
2016 -S$16.78 Million32.12%
2015 -S$12.7 Million-307.74%
2014 S$6.11 M-197.5%
2013 -S$6.27 Million
2010 -S$9.8 Million-14.02%
2009 -S$11.39 Million-57.28%
2008 -S$26.66 Million-8.03%
2007 -S$28.99 Million3.85%
2006 -S$27.92 Million39.31%
2005 -S$20.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-S$0.21 Billion 5,013.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-S$23.48 Million 482.11%๐Ÿ‡บ๐Ÿ‡ธ USA